SCHEMBL620196

SCHEMBL620196

CCCCOC(=O)N1CCCc2[nH]c3ccc(C)cc3c2C1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.74
PABPC1 P11940 1/20 0.74
ATM Q13315 1/20 0.74
SMN1; SMN2 Q16637 1/20 0.74
BAZ2B Q9UIF8 1/20 0.57
KDR P35968 3/20 0.55
NPC1 O15118 1/20 0.55
ALDH1A1 P00352 7/20 0.51
MAPT P10636 3/20 0.51
GAA P10253 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
CASP1 P29466 2/20 0.51
CASP7 P55210 2/20 0.51
USP2 O75604 1/20 0.51
KDM4E B2RXH2 2/20 0.51
HPGD P15428 1/20 0.51
HIF1A Q16665 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
SAE1 Q9UBE0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL620615 0.92 LMNA (0.87) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL620113 0.89 BAZ2B (0.58) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL407460 0.85 LMNA (1.00) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL621784 0.82 LMNA (0.50) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL10127719 0.81 LMNA (0.66) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL13356184 0.81 LMNA (0.65) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL11760636 0.79 SMN1; SMN2 (0.80) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL12868564 0.76 LMNA (0.78) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL541660 0.76 LMNA (0.78) LMNAPABPC1ATMSMN1; SMN2BAZ2B
SCHEMBL620479 0.76 BAZ2B (0.63) LMNAPABPC1ATMSMN1; SMN2BAZ2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040965-A1 SUBSTITUTED AZEPINO[4,3-B]INDOLES, PHARMACOLOGICAL COMPOSITION AND A METHOD FOR THE PRODUCTION AND USE THEREOF BORISOVICH FROLOV YEVGENIY (RU) 2012-02-16 US disclosed
EP-2062895-A1 SUBSTITUTED AZEPINO[4,3-B]INDOLES, PHARMACOLOGICAL COMPOSITION AND A METHOD FOR THE PRODUCTION AND USE THEREOF Alla Chem, LLC. (US) 2009-05-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040965-A1 SUBSTITUTED AZEPINO[4,3-B]INDOLES, PHARMACOLOGICAL COMPOSITION AND A METHOD FOR THE PRODUCTION AND USE THEREOF ABCG2, HTR3C, AADAC LMNA 2065/4885PABPC1 2188/4885ATM 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.